Literature DB >> 27118818

Association between Magnesium Disorders and Hypocalcemia following Thyroidectomy.

Jason C Nellis1, Ralph P Tufano1, Christine G Gourin2.   

Abstract

OBJECTIVE: To identify factors associated with postoperative hypocalcemia after thyroid surgery and to understand the relationship among hypocalcemia, length of hospitalization, and costs of care. STUDY
DESIGN: Retrospective database analysis.
METHODS: Discharge data from the Nationwide Inpatient Sample for 620,744 patients who underwent thyroid surgery from 2001 to 2010 were analyzed through cross-tabulations and multivariate regression modeling. Hypocalcemia, length of stay, and costs were examined as dependent variables. Secondary independent variables included magnesium and phosphate metabolism disorders, vitamin D deficiency, menopause, sex, extent of surgery, malignancy, and surgeon volume.
RESULTS: Hypocalcemia was reported in 6% of patients and was significantly more common for the following variables: women, age <65 years, patients from the Northeast, total thyroidectomy ± neck dissection patients, low-volume surgical care, malignancy, recurrent laryngeal nerve injury, and patients with disorders of magnesium or phosphate metabolism (P < .001). Magnesium and phosphate disorders were present in <1% of patients. Magnesium disorders were significantly more likely for patients with hypocalcemia (7%; P < .001), and hypocalcemia was present in 52% of patients with magnesium disorders (P < .001). On multiple logistic regression analysis, the odds of hypocalcemia were greatest for patients with magnesium disorders (odds ratio, 12.71; 95% confidence interval, 8.59-18.82). This relationship was not attenuated by high-volume surgical care. Hypocalcemia and magnesium disorders were both associated with increased length of stay and costs, with a greater effect for magnesium disorders than for hypocalcemia (P < .001).
CONCLUSIONS: Disorders of magnesium metabolism are an independent risk factor for postthyroidectomy hypocalcemia and are associated with significantly increased costs and length of stay. © American Academy of Otolaryngology—Head and Neck Surgery Foundation 2016.

Entities:  

Keywords:  Nationwide Inpatient Sample; hospital costs; hospital length of stay; hypocalcemia; magnesium disorders; surgery; thyroid neoplasms

Mesh:

Year:  2016        PMID: 27118818     DOI: 10.1177/0194599816644594

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  5 in total

1.  Association of Hypocalcemia and Magnesium Disorders With Thyroidectomy in Commercially Insured Patients.

Authors:  Rui Han Liu; Christopher R Razavi; Hsien-Yen Chang; Ralph P Tufano; David W Eisele; Christine G Gourin; Jonathon O Russell
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-03-01       Impact factor: 6.223

2.  The timing of parathyroid hormone measurement defines the cut-off values to accurately predict postoperative hypocalcemia: a prospective study.

Authors:  Eduardo Bardou Yunes Filho; Rafael Vaz Machry; Rodrigo Mesquita; Rafael Selbach Scheffel; Ana Luiza Maia
Journal:  Endocrine       Date:  2018-05-02       Impact factor: 3.633

3.  Unintentional parathyroidectomy during total thyroidectomy surgery: A single surgeon's experience.

Authors:  Wei Du; Qigen Fang; Xu Zhang; Meng Cui; Ming Zhao; Weihua Lou
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

4.  Risk factors for hypocalcemia and hypoparathyroidism following thyroidectomy: a retrospective Chinese population study.

Authors:  Ying-Hao Wang; Adheesh Bhandari; Fan Yang; Wei Zhang; Li-Jun Xue; Hai-Guang Liu; Xiao-Hua Zhang; Cheng-Ze Chen
Journal:  Cancer Manag Res       Date:  2017-11-15       Impact factor: 3.989

5.  Risk factors for postoperative hypocalcaemia after thyroidectomy: A systematic review and meta-analysis.

Authors:  Zhimei Chen; Qiyuan Zhao; Jinlei Du; Ya Wang; Rongrong Han; Caijuan Xu; Xiaofang Chen; Min Shu
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.